
Gilead appoints former Roche executive
pharmafile | September 9, 2016 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Gilead, Roche, appointment
Gilead Sciences has hired Rogers Luo as vice president and general manager of commercial operations in China. Luo formerly served as vice president at Shanghai Roche Pharmaceuticals.
His primary remit will be building the company’s commercial operations in China, preparing the potential launch of its hepatitis C and B treatments over the next few years.
Several of the firm’s drugs including Sovaldi remain unavailable to patients in the country thanks to a lengthy approval process which can cause years of delays. It will be Luo’s job to spearhead these issues in the region.
The Chinese Food and Drug Administration (CFDA) announced earlier this year that it seeking to revamp its processes, and noted that both Sovaldi and another Gilead product Harvoni would receive priority review, though it is not known how far away this may be.
Related Content

Gilead’s HIV treatment meets primary trial endpoint
Gilead has announced positive topline results from its phase 3 ARTISTRY-2 trial, which evaluated a …

Gilead announces first shipments of HIV prevention drug to Eswatini and Zambia
Gilead has announced the first shipments of its HIV prevention drug lenacapavir to Eswatini and …

Roche receives CE Mark for blood test to help rule out Alzheimer’s
Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …






